Biosynex SA commences an Equity Buyback Plan for 10% of its issued share capital, for €4.5 million, under the authorization approved on June 7, 2019.

Biosynex SA (ENXTPA:ALBIO) commences share repurchases on April 6, 2020, under the program mandated by the shareholders in the Annual General Meeting held on June 7, 2019. As per the mandate, the company is authorized to repurchase up to 10% of the share capital, for a total for €4.5 million. The shares will be repurchased at a price of €31 per share. The program will be valid for 18 months. On February 12, 2020, the company initiated a share repurchase program. Under the program, the company will repurchase up to 679,544 shares for €3.40 million. The shares will be repurchased at a price of €5 per share. The program will be valid till December 6, 2020. As of February 10, 2020, the company has 234,000 ordinary shares.